On the Road
Stephen Rapundalo, PhD
President & CEO
The end of 2014 and beginning of the New Year was supposed to be a quiet time to regroup and refresh. Instead it turned into a whirlwind of reviewing, preparation, coordinating, and more planning. Staff and I took the opportunity over the holidays to assess MichBio's activities, programs, and value proposition. Such an exercise is conducted every year anyways, but this time called for an even deeper dive than normal. [Read more 'On the Road']
Statewide Bio-Industry Strategic Planning Effort Launched
MichBio has launched a statewide effort to develop a five-year strategic plan for growing Michigan's biosciences industry. The initiative is being conducted in partnership with the Business Leaders for Michigan and the University Research Corridor. [Learn more and get involved]
|Full Steam Ahead
Recap of 2015 JPMorgan Healthcare Week
The 33rd JPMorgan Healthcare Conference didn't disappoint. This year JPM brought together 10,000 investors, company executives, analysts, shareholders, and others to hear over 300 public and select private company, as well as health system presentations. The buzz level was noticeably up... with an unmistakable attitude of "damn the torpedoes, full speed ahead." [More]
We're looking for Committee Volunteers
MichBio is seeking volunteers from its member companies in good standing for the following committees:
- Medical Devices & Technologies
- Clinical Trials (groups conducting trials, especially Phase 1)
- Bio-Economy & Bio-Based Technologies (i.e., ag- and industrial biotech)
- Contract Research Organizations (pre-clinical, clinical, sales, manufacturing, etc. - all sectors)
Welcome New Members!
The Domann Organization, Inc.
The Domann Organization, Leadership for the Life Sciences, has built our practice on knowledge, cultivation, and leadership. Since 1988 Domann has focused exclusively on building executive teams for Life Sciences and primarily worked with startups and the venture community. Our investment has resulted in our demonstrated advantage of identifying the proven life science leadership that presents the greatest potential for strategic growth and success. We are committed to partnering with our clients to guarantee delivery of the greatest asset: human capital.
Specializing in helping emergent specialty pharma and biotech enter the U.S. market, New Perspectives' capabilities span the spectrum of product development and commercialization. From your first interaction with FDA to managing market access, through to brand entry post approval, we deliver. We bring the creative and innovative approaches, uniquely developed to fit your organizational needs and market conditions, to deliver results in today's ever-changing landscape.
In 2009 while pursuing a doctoral degree at the University of Toledo, the funding of Sean Seaver's research lab began to run low. In an effort to save money Sean created a spreadsheet of the chemicals and supplies needed to finish his research, along with the company with the best price on each item. In 2010, P212121 was created to help its customers find the lowest prices on all lab items, making grants last longer.